Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2015 04/14/2015 04/15/2015 04/16/2015 04/17/2015 Date
182.9(c) 182.72(c) 183.83(c) 184.28(c) 181.34(c) Last
873 519 879 668 777 200 611 753 1 063 661 Volume
+0.12% -0.10% +0.61% +0.24% -1.60% Change
More quotes
Financials ($)
Sales 2015 2 625 M
EBIT 2015 1 305 M
Net income 2015 910 M
Finance 2015 2 785 M
Yield 2015 -
Sales 2016 3 275 M
EBIT 2016 1 725 M
Net income 2016 1 199 M
Finance 2016 4 223 M
Yield 2016 -
PER 2015 41,77
PER 2016 31,08
EV / Sales 2015 12,7x
EV / Sales 2016 9,77x
Capitalization 36 202 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
04/23Earnings Release
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
04/16 ALEXION PHARMACEUTICALS : Updates on Presentations at 2015 American Transplant C..
04/13 ALEXION PHARMACEUTICALS : Announces Presentations at 2015 American Transplant Co..
04/10 ALEXION PHARMACEUTICALS : Technical Analysis on Biotech Equities -- Achillion Ph..
04/09 ALEXION PHARMACEUTICALS : to Report First Quarter 2015 Results on Thursday, Apri..
04/07 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers, Financial S..
03/26 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
03/16 ALEXION PHARMACEUTICALS : Entry into a Material Definitive Agreement, Terminatio..
03/10 ALEXION PHARMACEUTICALS : Coverage of Biotech Equities -- MannKind, Novavax, Cur..
More news
Sector news : Biopharmaceuticals
01:08a JOHNSON & JOHNSON : Court OKs $63m award in Children's Motrin case
04/17 TEVA PHARMACEUTICAL : BRIEF: Mylan says it is not interested in merger with Isra..
04/17 TEVA PHARMACEUTICAL : Mylan discounts speculation of a possible takeover by Teva
More sector news : Biopharmaceuticals
News from SeekingAlpha
04/17 NEXT WEEK IN BIOTECH : Amgen, AbbVie, Biogen Earnings, UniQure CHMP, AAN Meeting
04/10 SEEKING ALPHA'S BIOTECH WEEKLY : A Biogen Deep Dive, Eisai's Arena Shuffle, And ..
04/10 Updated label cleared in Europe for Alexion's Soliris
04/07 Alexion Pharma Is A 'Wait And See' Story
03/31 Strong Dollar Hurts Profit Forecasts In Long Term


Comments 
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF